Experience market stability with numerous untapped opportunities for growth in the pharmaceuticals sector, and become aware of obstacles and strategies for getting and securing funding amid big players.
With an annual 20% growth, the pharmaceutical industry market has become a stable fertile ground for innovations. AI assistance, telehealth, and evolving healthcare needs, fueled by covid-19, have fostered venture capitalists to allocate more resources to the pharmaceuticals segment.
Big players have raised the bar, making it hard for fresh blood to flow into the market smoothly. The names of Pfizer Inc., Johnson & Johnson, and Roche Holding AG are on everyone’s lips. Endowed with a strong brand and substantial resources, they have gained both customers’ and investors’ trust, thus leading to another hurdle…
A fight for financing. The risks associated with monetary returns and time-related challenges in drug discovery and manufacturing may cut the chances of your project funding. But…
To stay ahead of the curve in the pharmaceutical industry, startups should utilize a comprehensive systematic approach and know how to address the competitive landscape. With a track record of successful fundraising cases and business growth plans, at Waveup, we know all the ropes of this game. So let’s start delving into the promising pharmaceutics arena by reviewing our market research.
in funding early-stage drug startups from 2020 to 2021.
an aging population with an expected number of 2b by 2050 is rocketing healthcare demands.
every 3 seconds, people buy pharmaceutical products.
pharmaceuticals innovation drives 70% of medical breakthroughs.
is the healthcare market share of the pharmaceuticals industry.
And the leading verticals are:
Stability and growth potential come at a cost.
The pharmaceutical market arena witnesses a considerable battle between established pharma companies and new entrants. The early-stage startups should cover all the bases since, with extensive resources and well-known brand names, pharmaceutical giants stand as a significant challenge on the horizon.
Getting fundraising in pharmaceuticals is a rough road. And the industry’s unique nature is the driving force behind it. Long time and high risks associated with drug discovery and development and uncertain investment returns lower the chances of attracting the required financial support.
Exploring uncharted waters is profitable yet challenging. Each country has its own set of regulations, approval procedures, and funding channels that pharmaceutical cadets must navigate. Additionally, the product’s success in the market depends on patient demographics, treatment protocols, and healthcare infrastructure.
From diligent industry analysis to storytelling and financial forecasts, we’re helping founders crystallize and structure key business fundamentals and translate them into a compelling investment opportunity framed in a winning pharmaceuticals pitch deck.
Evaluating potential investments, conducting due diligence, and supporting portfolio companies on their new fundraising rounds.
Discovering market opportunities in the market and developing execution strategies to build actionable and scalable blueprints for growth.
WHO WE ARE
The pharmaceutical industry offers promising financing opportunities due to its constant innovation, the ever-present demand for novel medical solutions and treatments, and a rapidly growing market comprising more than $1.1T. Plus, with the potential for high returns on successful drug developments and the growing global emphasis on healthcare, investors view it as a lucrative sector for long-term investment.
The comprehensive pharmaceutical market research showed that the global market was valued at $1.1 in 2022 and is projected to skyrocket at the rate of 5.8% yearly. With the continuous evolution in biotech, personalized medicine, and digital health, there’s enormous potential for upcoming pharmaceutical startups.
The pharmaceutical industry seems to be on VCs’ 2023 radars due to the ever-lasting necessity for health sustaining and promoting, but securing funding is not a walk in the park. High costs and risks associated with drug development and lengthy regulatory processes may deter investors from pouring funds into your startup. However, with cutting-edge innovation and effective go-to-market strategy, you’ll conquer the hearts and wallets of both clients and venture capitalists.
Crafting a pharmaceutical pitch deck usually takes from two to three weeks. However, if the project is complicated, the time frames may vary up to a month. The exact amount of time needed to complete the project is discussed individually.
We have noticed a number of crucial mistakes startups make in their pharmaceutical pitch decks. First, they don’t put too much emphasis on investment narration, and this constitutes almost half of a pitch deck’s success. Second, their presentations lack such essential aspects as market traction, the answer to the question ‘Why now?,’ and relevant information.
Pharmaceutical startups face fierce competition, high research and development costs, and regulatory hurdles. To tackle these issues, many are turning to partnerships and collaborations for shared resources, leveraging AI for drug discovery, and seeking diverse funding sources.
The pharmaceutical market is cutthroat, with numerous established giants and more than 2K emerging players vying for market share, breakthrough innovations, and patent rights. The race for drug discovery, coupled with the complexities of legal protocols, keeps the market dynamics continuously in flux.
Detailed due diligence of the promising m-commerce projects, supporting making a decision as for the opportunity value, and A to Z fundraising assistance to the partner fund’s group of companies—are the scope of services we provide to venture capitalists.
Definitely! Whether you need to identify pharmaceutical M&A opportunities, create a CIM, or require a model for buy-side and sell-side deals, we are at your service.
Surely! One of the services we provide is assisting startups in contacting pharmaceutical VCs if their projects align with the requirements, such as round size, team, product, etc. Plus, we create a pipeline of investors eager to pour funds into pharmaceuticals to arrange a meeting for the startups with them, with further post-deal communication.
Certainly! Our experts offer tailored insights into the pharmaceutical scene, encompassing sector overviews, competitor breakdowns, and thorough market studies to prime you for triumph. We tap into trusted exclusive databases to ensure you fully understand the nuances of the pharmaceutical sector, touching on aspects like its scale, variety, and rivalry.
We help pharmaceutical startups by guiding them through the Seed to Series B growth stages, along with assistance in pre-seed and Series C+ stages and cooperation with top industry players and VC funds.
Leverage Waveup’s unmatched expertise in fundraising, M&A advisory, and growth hacking to take your project to the next level. Share your email, and let's discuss how we can help!
Dive deep into industry research with unparalleled depth and breadth
Equip yourself with the analysis and forecasts essential for strategic planning
Understand today’s trends and anticipate tomorrow’s shifts to ensure your business stays ahead